FDA — authorised 1 July 2024
- Application: ANDA212785
- Marketing authorisation holder: SUN PHARM INDS INC
- Local brand name: INDIUM IN-111 PENTETREOTIDE KIT
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 OCTREOSCAN in United States
FDA authorised OCTREOSCAN on 1 July 2024
Marketing authorisations
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is OCTREOSCAN approved in United States?
Yes. FDA authorised it on 1 July 2024; FDA has authorised it.
Who is the marketing authorisation holder for OCTREOSCAN in United States?
SUN PHARM INDS INC holds the US marketing authorisation.